Penobscot Investment Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Hold |
19,450
| – | – | 0.11% | 154 |
|
|
2025
Q1 | $1.23M | Hold |
19,450
| – | – | 0.12% | 147 |
|
|
2024
Q4 | $1.29M | Buy |
19,450
+450
| +2% | +$29.9K | 0.12% | 143 |
|
|
2024
Q3 | $1.39M | Sell |
19,000
-900
| -5% | -$65.8K | 0.12% | 144 |
|
|
2024
Q2 | $1.29M | Buy |
19,900
+8,000
| +67% | +$519K | 0.12% | 141 |
|
|
2024
Q1 | $770K | Buy |
11,900
+750
| +7% | +$48.5K | 0.08% | 170 |
|
|
2023
Q4 | $734K | Buy |
11,150
+1,300
| +13% | +$85.6K | 0.09% | 169 |
|
|
2023
Q3 | $562K | Buy |
+9,850
| New | +$562K | 0.08% | 172 |
|